Neuropsychological Features of Mild Cognitive Impairment in Parkinson’s Disease: A Critical Review of the Literature

Authors

  • Emanuela Castro Hospital Psychology, Fifth Sanitary Authority, Via Cocchi, 56126, Pisa, Italy
  • Marco Timpano Sportiello Hospital Psychology, Fifth Sanitary Authority, Via Cocchi, 56126, Pisa, Italy and Department of Surgical, Medical, Molecular, and Critical Area Pathology, Pisa University School of Medicine, 56126, Pisa, Italy
  • Davide Maria Cammisuli Department of Surgical, Medical, Molecular, and Critical Area Pathology, Pisa University School of Medicine, 56126, Pisa, Italy

DOI:

https://doi.org/10.12974/2309-6128.2014.02.02.5

Keywords:

Parkinson’s disease, mild cognitive impairment, diagnostic criteria, epidemiology, neuropsychology, assessment, non-pharmacological treatment.

Abstract

Motor features traditionally define Parkinson’s disease (PD), but non-motor characteristics such as cognitive impairment and dementia have been gradually documented as a core part of PD. Mild cognitive impairment, as a pre-dementia phase of cognitive dysfunction, is recognised as common in non-demented PD patients. In any case, before Parkinson’s Disease-Mild Cognitive Impairment (PD-MCI) diagnostic criteria proposed by the Movement Disorder Society (MDS) Task Force in 2012, there was no agreement in the scientific community about definition, clinical features and evolution of PD-MCI. It explains why epidemiological data reported by many studies provide contrasting results. Nevertheless, many investigations have pointed out that a large amount of PD patients without dementia present a specific neuropsychological impairment, mainly characterized by executive, visuospatial and memory deficits. This review focuses on mild cognitive impairment in PD (PD-MCI). To clarify the characterization of PD-MCI neuropsychological profile, a MEDLINE literature search was carried out. Data were extracted from studies published since 1980. The neurocognitive profile of PD patients was heterogeneous. Cognitive impairment was common in PD even at the time of diagnosis and before drug treatment and it was associated with functional impairment. Primary findings reported that single domain impairment with executive dysfunction was more common than multiple domain impairment, but, nowadays, those results are largely criticized. Moreover, visual-space abilities deteriorated very early during the pathology. Patients with posterior cortical deficits seemed to be associated with the development of Parkinson’s Disease Dementia (PD-D), whereas patients with front striatal deficits were not, hence suggesting the presence of two distinct cognitive syndromes with different aetiologies and prognoses. However, several questions regarding PD-MCI criteria remain currently unanswered. More attention must be paid to the definition of best cut-off scores and to accurate, specific and sensitive tests for discriminating between patients with and without PD-MCI. Further investigations should define the exact prevalence of PD-MCI across different sites/cohort types, estimate PD-MCI subtypes prevalence and even link the clinical phenotype (akinetic-rigid vs tremor-dominant) to the different neuropsychological profiles. Furthermore, research needs to focus on detecting the neuropsychological predictors of PD-MCI conversion into PD-D. Poor efficacy of non-pharmacological intervention to delay the onset of PD-D in PD-MCI patients is also discussed. 

References

Parkinson J. An essay on the shaking palsy: Whittingham and Rowland; 1817.

TEIVE HA. The Charcot's contribution in the Parkinson's disease. Arquivos de Neuro-Psiquiatria. 1998; 56: 141-5. http://dx.doi.org/10.1590/S0004-282X1998000100026

Williams-Gray C, Foltynie T, Brayne C, Robbins T, Barker R. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain: A Journal of Neurology. 2007; 130(7): 1787-98. http://dx.doi.org/10.1093/brain/awm111

Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, et al. Defining mild cognitive impairment in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2007 Jul 15; 22(9): 1272- 7. http://dx.doi.org/10.1002/mds.21453

Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain: A Journal of Neurology. 2009 Nov; 132(Pt 11): 2958-69.

Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology. 2009 Mar 31; 72(13): 1121-6. http://dx.doi.org/10.1212/01.wnl.0000338632.00552.cb

Mahieux F, Fénelon G, Flahault A, Manifacier M-J, Michelet D, Boller F. Neuropsychological prediction of dementia in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry. 1998; 64(2): 178-83. http://dx.doi.org/10.1136/jnnp.64.2.178

Levy G, Jacobs DM, Tang MX, Côté LJ, Louis ED, Alfaro B, et al. Memory and executive function impairment predict dementia in Parkinson's disease. Movement Disorders. 2002; 17(6): 1221-6. http://dx.doi.org/10.1002/mds.10280

Janvin CC, Aarsland D, Larsen JP. Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. Journal of Geriatric Psychiatry and Neurology. 2005 Sep; 18(3): 149-54. http://dx.doi.org/10.1177/0891988705277540

Jacobs DM, Marder K, Cote L, Sano M, Stern Y, Mayeux R. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology. 1995; 45(9): 1691-6. http://dx.doi.org/10.1212/WNL.45.9.1691

Association AP. The Diagnostic and Statistical Manual of Mental Disorders: DSM 5: bookpointUS; 2013.

Janvin C, Aarsland D, Larsen JP, Hugdahl K. Neuropsychological profile of patients with Parkinson's disease without dementia. Dementia and Geriatric Cognitive Disorders. 2003; 15(3): 126-31. http://dx.doi.org/10.1159/000068483

Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Movement Disorders. 2004; 19(9): 1043-9. http://dx.doi.org/10.1002/mds.20216

Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine. 2004; 256(3): 183-94. http://dx.doi.org/10.1111/j.1365-2796.2004.01388.x

Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology. 1999; 56(3): 303-8. http://dx.doi.org/10.1001/archneur.56.3.303

Petersen R. Normal aging, mild cognitive impairment, and early Alzheimer's disease. Neurologist. 1995; 1(6): 326-44.

Dalrymple-Alford JC, Livingston L, MacAskill MR, Graham C, Melzer TR, Porter RJ, et al. Characterizing mild cognitive impairment in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2011 Mar; 26(4): 629-36. http://dx.doi.org/10.1002/mds.23592

Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009 Nov 24; 73(21): 1738-45. http://dx.doi.org/10.1212/WNL.0b013e3181c34b47

Caviness JN, Hentz JG, Evidente VG, Driver-Dunckley E, Samanta J, Mahant P, et al. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease. Parkinsonism & Related Disorders. 2007 Aug; 13(6): 348-54. http://dx.doi.org/10.1016/j.parkreldis.2007.01.003

Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Movement Disorders: Official Journal of the Movement Disorder Society. 2006 Sep; 21(9): 1343-9. http://dx.doi.org/10.1002/mds.20974

Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders: Official Journal of the Movement Disorder Society. 2012 Mar; 27(3): 349-56. http://dx.doi.org/10.1002/mds.24893

Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain: A Journal of Neurology. 2004; 127(3): 550-60. http://dx.doi.org/10.1093/brain/awh067

Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, et al. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Movement Disorders: Official Journal of the Movement Disorder Society. 2011 Aug 15; 26(10): 1814-24.

Levin BE, Llabre MM, Weiner WJ. Cognitive impairments associated with early Parkinson's disease. Neurology.

[Research Support, Non-U.S. Gov't]. 1989 Apr; 39(4): 557- 61.

Dubois B, Pillon B. Cognitive deficits in Parkinson's disease. Journal of Neurology. 1996; 244(1): 2-8. http://dx.doi.org/10.1007/PL00007725

Troster AI, Fields JA. Frontal cognitive function and memory in Parkinson's disease: toward a distinction between prospective and declarative memory impairments? Behav Neurol. 1995; 8(2): 59-74. http://dx.doi.org/10.1155/1995/167286

Stefanova E, Kostic VS, Ziropadja L, Ocic G, Markovic M. Declarative memory in early Parkinsons disease: Serial position learning effects. Journal of Clinical and Experimental Neuropsychology. 2001; 23(5): 581-91. http://dx.doi.org/10.1076/jcen.23.5.581.1239

Gotham A, Brown R, Marsden C. 'Frontal'cognitive function in patients with Parkinson's disease 'on'and 'off'levodopa. Brain: A Journal of Neurology. 1988; 111(2): 299-321. http://dx.doi.org/10.1093/brain/111.2.299

Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain: A Journal of Neurology. 1991; 114(5): 2095-122. http://dx.doi.org/10.1093/brain/114.5.2095

Owen AM, Beksinska M, James M, Leigh P, Summers B, Marsden C, et al. Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia. 1993; 31(7): 627-44. http://dx.doi.org/10.1016/0028-3932(93)90135-M

Postle BR, Jonides J, Smith EE, Corkin S, Growdon JH. Spatial, but not object, delayed response is impaired in early Parkinson's disease. Neuropsychology. 1997; 11(2): 171. http://dx.doi.org/10.1037/0894-4105.11.2.171

Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurology. 2010 Dec; 9(12): 1200-13. http://dx.doi.org/10.1016/S1474-4422(10)70212-X

Bowen FP. Behavioral alterations in patients with basal ganglia lesions. Research Publications-Association for Research in Nervous and Mental Disease. 1975; 55: 169-80.

Morris RG, Downes JJ, Sahakian BJ, Evenden JL, Heald A, Robbins TW. Planning and spatial working memory in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry. 1988; 51(6): 757-66. http://dx.doi.org/10.1136/jnnp.51.6.757

Owen A, James M, Leigh P, Summers B, Marsden C, Quinn N, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain: A Journal of Neurology. 1992; 115(6): 1727-51. http://dx.doi.org/10.1093/brain/115.6.1727

Taylor AE, Saint-Cyr JA. The neuropsychology of Parkinson's disease. Brain Cogn.

[Review]. 1995 Aug; 28(3): 281-96. http://dx.doi.org/10.1006/brcg.1995.1258

Straits-Tröster K, Fields JA, Wilkinson SB, Pahwa R, Lyons KE, Koller WC, et al. Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulation. Brain Cogn. 2000; 42(3): 399-416. http://dx.doi.org/10.1006/brcg.1999.1112

Cools R, Barker RA, Sahakian BJ, Robbins TW. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia. 2003; 41(11): 1431-41. http://dx.doi.org/10.1016/S0028-3932(03)00117-9

Kehagia AA, Cools R, Barker RA, Robbins TW. Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson's disease. Neuropsychologia. 2009; 47(4): 1117-27. http://dx.doi.org/10.1016/j.neuropsychologia.2009.01.002

Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, et al. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism & Related Disorders. 2009 Mar; 15(3): 226-31. http://dx.doi.org/10.1016/j.parkreldis.2008.05.006

Braak H, Tredici KD, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging. 2003; 24(2): 197-211. http://dx.doi.org/10.1016/S0197-4580(02)00065-9

Pillon B, Deweer B, Agid Y, Dubois B. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Archives of Neurology. 1993; 50(4): 374-9. http://dx.doi.org/10.1001/archneur.1993.00540040036010

Raskin SA, Sliwinski M, Borod JC. Clustering strategies on tasks of verbal fluency in Parkinson's disease. Neuropsychologia. 1992; 30(1): 95-9. http://dx.doi.org/10.1016/0028-3932(92)90018-H

Henry JD, Crawford JR. Verbal fluency deficits in Parkinson's disease: a meta-analysis. Journal of the International Neuropsychological Society. 2004; 10(04): 608-22. http://dx.doi.org/10.1017/S1355617704104141

Buytenhuijs EL, Berger HJ, Van Spaendonck KP, Horstink MW, Borm GF, Cools AR. Memory and learning strategies in patients with Parkinson's disease. Neuropsychologia. 1994; 32(3): 335-42. http://dx.doi.org/10.1016/0028-3932(94)90135-X

Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. Journal of the American Geriatrics Society. 2004; 52(5): 784-8. http://dx.doi.org/10.1111/j.1532-5415.2004.52219.x

Massman PJ, Delis DC, Butters N, Levin BE, Salmon DP. Are all subcortical dementias alike?: Verbal learning and memory in Parkinson's and Huntington's disease patients. Journal of Clinical and Experimental Neuropsychology. 1990; 12(5): 729-44. http://dx.doi.org/10.1080/01688639008401015

Stern Y, Marder K, Tang MX, Mayeux R. Antecedent clinical features associated with dementia in Parkinson's disease. Neurology. 1993; 43(9): 1690. http://dx.doi.org/10.1212/WNL.43.9.1690

Faglioni P, Saetti MC, Botti C. Verbal learning strategies in Parkinson's disease. Neuropsychology. 2000; 14(3): 456. http://dx.doi.org/10.1037/0894-4105.14.3.456

Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004; 318(1): 121-34. http://dx.doi.org/10.1007/s00441-004-0956-9

Wilson RS, Kaszniak A, Klawans HL, Garron DC. High speed memory scanning in parkinsonism. Cortex; 1980; 16(1): 67- 72. http://dx.doi.org/10.1016/S0010-9452(80)80022-0

Bradley VA, Welch JL, Dick DJ. Visuospatial working memory in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry. 1989; 52(11): 1228-35. http://dx.doi.org/10.1136/jnnp.52.11.1228

Cooper J, Sagar H, Doherty S, Jordan N, Tidswell P, Sullivan E. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in parkinson's disease a follow-up study of untreated patients. Brain 1992; 115(6): 1701-25. http://dx.doi.org/10.1093/brain/115.6.1701

Cooper J, Sagar H, Sullivan E. Short-term memory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication. Neuropsychologia. 1993; 31(9): 933-49. http://dx.doi.org/10.1016/0028-3932(93)90149-T

Owen AM, Iddon JL, Hodges JR, Summers BA, Robbins TW. Spatial and non-spatial working memory at different stages of Parkinson's disease. Neuropsychologia. 1997; 35(4): 519-32. http://dx.doi.org/10.1016/S0028-3932(96)00101-7

Pillon B, Deweer B, Vidailhet M, Bonnet A-M, Hahn-Barma V, Dubois B. Is impaired memory for spatial location in Parkinson's disease domain specific or dependent on 'strategic'processes? Neuropsychologia. 1998; 36(1): 1-9. http://dx.doi.org/10.1016/S0028-3932(97)00102-4

Bras CL, Pillon B, Damier P, Dubois B. At which steps of spatial working memory processing do striatofrontal circuits intervene in humans? Neuropsychologia. 1998; 37(1): 83-90. http://dx.doi.org/10.1016/S0028-3932(98)00041-4

Diederich NJ, Raman R, Leurgans S, Goetz CG. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Archives of Neurology. 2002; 59(8): 1249-52. http://dx.doi.org/10.1001/archneur.59.8.1249

Heindel WC, Salmon DP, Shults CW, Walicke PA, Butters N. Neuropsychological evidence for multiple implicit memory systems: A comparison of Alzheimer's, Huntington's, and Parkinson's disease patients. The Journal of Neuroscience. 1989; 9(2): 582-7.

Huberman M, Moscovitch M, Freedman M. Comparison of patients with Alzheimer's and Parkinson's disease on different explicit and implicit tests of memory. Cognitive and Behavioral Neurology. 1994; 7(3): 185-93.

Knowlton BJ, Mangels JA, Squire LR. A neostriatal habit learning system in humans. Science. 1996; 273(5280): 1399- 402. http://dx.doi.org/10.1126/science.273.5280.1399

Ferraro FR, Balota DA, Connor LT. Implicit Memory and the Formation of New Associations in Nondemented Parkinson???? s Disease Individuals and Individuals with Senile Dementia of the Alzheimer Type: A Serial Reaction Time (SRT) Investigation. Brain Cogn. 1993; 21(2): 163-80. http://dx.doi.org/10.1006/brcg.1993.1013

Jackson GM, Jackson SR, Harrison J, Henderson L, Kennard C. Serial reaction time learning and Parkinson's disease: Evidence for a procedural learning deficit. Neuropsychologia. 1995; 33(5): 577-93. http://dx.doi.org/10.1016/0028-3932(95)00010-Z

Smith J, Siegert RJ, McDowall J, Abernethy D. Preserved implicit learning on both the serial reaction time task and artificial grammar in patients with Parkinson's disease. Brain Cogn. 2001; 45(3): 378-91. http://dx.doi.org/10.1006/brcg.2001.1286

Troster AI, Paolo AM, Lyons KE, Glatt SL, Hubble JP, Koller WC. The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease. Neurology.

[Research Support, U.S. Gov't, P.H.S.]. 1995 Apr; 45(4): 672-6.

Altgassen M, Zollig J, Kopp U, Mackinlay R, Kliegel M. Patients with Parkinson's disease can successfully remember to execute delayed intentions. Journal of the International Neuropsychological Society: JINS.

[Research Support, Non-U.S. Gov't]. 2007 Sep; 13(5): 888-92.

McDaniel MA, Einstein GO. Prospective memory: An overview and synthesis of an emerging field: Sage Publications; 2007.

Costa A, Peppe A, Caltagirone C, Carlesimo GA. Prospective memory impairment in individuals with Parkinson's disease. Neuropsychology. 2008; 22(3): 283. http://dx.doi.org/10.1037/0894-4105.22.3.283

Costa A, Caltagirone C. Malattia di Parkinson e parkinsonismi: Springer; 2009. http://dx.doi.org/10.1007/978-88-470-1490-9

Foster ER, McDaniel MA, Repov???? G, Hershey T. Prospective memory in Parkinson disease across laboratory and selfreported everyday performance. Neuropsychology. 2009; 23(3): 347. http://dx.doi.org/10.1037/a0014692

Choudhry R, Saint-Cyr J, editors. Self-report on memory abilities and prospective memory in Parkinson's disease. Brain Cogn; 2001: Academic Press INC 525 B ST, STE 1900, San Diego, CA 92101-4495 USA.

Katai S. Everyday memory impairment in Parkinson's disease. Rinsh???? shinkeigaku. Clinical Neurology. 1999; 39(9): 913.

Katai S, Maruyama T, Hashimoto T, Ikeda S. Event based and time based prospective memory in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry. 2003; 74(6): 704-9. http://dx.doi.org/10.1136/jnnp.74.6.704

Altgassen M, Phillips L, Kopp U, Kliegel M. Role of working memory components in planning performance of individuals with Parkinson's disease. Neuropsychologia. 2007; 45(10): 2393-7. http://dx.doi.org/10.1016/j.neuropsychologia.2007.02.018

Raskin SA, Woods SP, Poquette AJ, McTaggart AB, Sethna J, Williams RC, et al. A differential deficit in time-versus event-based prospective memory in Parkinson's disease. Neuropsychology. 2011; 25(2): 201. http://dx.doi.org/10.1037/a0020999

Lieberman P, Kako E, Friedman J, Tajchman G, Feldman LS, Jiminez EB. Speech production, syntax comprehension, and cognitive deficits in Parkinson's disease. Brain and Language. 1992; 43(2): 169-89. http://dx.doi.org/10.1016/0093-934X(92)90127-Z

Grossman M, Crino P, Reivich M, Stem MB, Hurtig HI. Attention and sentence processing deficits in Parkinson's disease: the role of anterior cingulate cortex. Cerebral Cortex. 1992; 2(6): 513-25. http://dx.doi.org/10.1093/cercor/2.6.513

Troster AI, Woods SP. Neuropsychological aspects of Parkinson's disease and parkinsonian syndromes. Handbook of Parkinson's Disease. 2003: 127-57.

Dadgar H, Khatoonabadi AR, Bakhtiyari J. Verbal Fluency Performance in Patients with Non-demented Parkinson's Disease. Iranian Journal of Psychiatry. 2013 Mar; 8(1): 55-8.

Troyer AK, Moscovitch M, Winocur G, Leach L, Freedman M. Clustering and switching on verbal fluency tests in Alzheimer's and Parkinson's disease. Journal of the International Neuropsychological Society: JINS.

[Clinical Trial Research Support, Non-U.S. Gov't]. 1998 Mar; 4(2): 137-43.

Huber SJ, Shuttleworth EC, Paulson GW. Dementia in Parkinson's disease. Archives of Neurology. 1986; 43(10): 987-90. http://dx.doi.org/10.1001/archneur.1986.00520100009006

Brown R, Marsden C. Visuospatial function in Parkinson's disease. Brain: A Journal of Neurology. 1986; 109(5): 987- 1002. http://dx.doi.org/10.1093/brain/109.5.987

Bondi MW, Kaszniak AW, Bayles KA, Vance KT. Contributions of frontal system dysfunction to memory and perceptual abilities in Parkinson's disease. Neuropsychology. 1993; 7(1): 89. http://dx.doi.org/10.1037/0894-4105.7.1.89

Bowen FP, Hoehn MM, Yahr MD. Parkinsonism: alterations in spatial orientation as determined by a route-walking test. Neuropsychologia. 1972; 10(3): 355-61. http://dx.doi.org/10.1016/0028-3932(72)90027-9

Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010 Nov 9; 75(19): 1717-25. http://dx.doi.org/10.1212/WNL.0b013e3181fc29c9

Gill DJ, Freshman A, Blender JA, Ravina B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2008 May 15; 23(7): 1043-6. http://dx.doi.org/10.1002/mds.22017

Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology. 2008 Apr 15; 70(16 Pt 2): 1470-7. http://dx.doi.org/10.1212/01.wnl.0000304050.05332.9c

Petrova M, Raycheva M, Zhelev Y, Traykov L. Executive functions deficit in Parkinson's disease with amnestic mild cognitive impairment. American Journal of Alzheimer's Disease and other Dementias. 2010 Aug; 25(5): 455-60. http://dx.doi.org/10.1177/1533317510370956

Gagnon JF, Vendette M, Postuma RB, Desjardins C, Massicotte-Marquez J, Panisset M, et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Annals of Neurology. 2009 Jul; 66(1): 39-47. http://dx.doi.org/10.1002/ana.21680

Aarsland D, Brønnick K, Larsen JP, Tysnes OB, Alves G. Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest study. Neurology. 2009; 72(13): 1121-6. http://dx.doi.org/10.1212/01.wnl.0000338632.00552.cb

Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology. 2010 Sep 21; 75(12): 1062-9. http://dx.doi.org/10.1212/WNL.0b013e3181f39d0e

Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993. http://dx.doi.org/10.1212/WNL.43.11.2412-a

Pagonabarraga J, Kulisevsky J, Llebaria G, Garcia-Sanchez C, Pascual-Sedano B, Gironell A. Parkinson's diseasecognitive rating scale: a new cognitive scale specific for Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society. 2008 May 15; 23(7): 998- 1005.

Sollinger AB, Goldstein FC, Lah JJ, Levey AI, Factor SA. Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism & Related Disorders. 2010 Mar; 16(3): 177-80. http://dx.doi.org/10.1016/j.parkreldis.2009.11.002

Tedrus GMAS, Fonseca LC, Letro GH, Bossoni AS, Samara AB. Dementia and mild cognitive impairment in Parkinson's disease: The authors' reply. Arquivos de Neuro-Psiquiatria. 2009; 67(4). http://dx.doi.org/10.1590/S0004-282X2009000600038

Muslimovi???? D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. 2005; 65(8): 1239-45. http://dx.doi.org/10.1212/01.wnl.0000180516.69442.95

Song IU, Kim JS, Jeong DS, Song HJ, Lee KS. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia. Parkinsonism & Related Disorders. 2008 Nov; 14(7): 558-62. http://dx.doi.org/10.1016/j.parkreldis.2008.01.007

Jak AJ, Bangen KJ, Wierenga CE, Delano-Wood L, Corey- Bloom J, Bondi MW. Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment. International Review of Neurobiology. 2009; 84: 81-103. http://dx.doi.org/10.1016/S0074-7742(09)00405-X

Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3): 189-98. http://dx.doi.org/10.1016/0022-3956(75)90026-6

Athey RJ, Porter RW, Walker RW. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment- Revised (CAMCOG-R). Age and Ageing. 2005 May; 34(3): 268-73. http://dx.doi.org/10.1093/ageing/afi098

Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RM, Wadia P, et al. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2008 Jan 30; 23(2): 297-9.

Hu MT, Szewczyk-Krolikowski K, Tomlinson P, Nithi K, Rolinski M, Murray C, et al. Predictors of cognitive impairment in an early stage Parkinson's disease cohort. Movement Disorders: Official Journal of the Movement Disorder Society. 2014 Jan 6.

Kulisevsky J, Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Movement Disorders. 2009; 24(8): 1103-10. http://dx.doi.org/10.1002/mds.22506

Pagonabarraga J, Kulisevsky J, Llebaria G, García-Sánchez C, Pascual-Sedano B, Martinez-Corral M, et al. PDD-Short Screen: A brief cognitive test for screening dementia in Parkinson's disease. Movement Disorders. 2010; 25(4): 440- 6. http://dx.doi.org/10.1002/mds.22877

Mahieux F, Michelet D, Manifacier M-J, Boller F, Fermanian J, Guillard A. Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease. Behav Neurol. 1995; 8(1): 15-22. http://dx.doi.org/10.1155/1995/304876

Marinus J, Visser M, Verwey N, Verhey F, Middelkoop H, Stiggelbout A, et al. Assessment of cognition in Parkinson's disease. Neurology. 2003; 61(9): 1222-8. http://dx.doi.org/10.1212/01.WNL.0000091864.39702.1C

Isella V, Mapelli C, Morielli N, Siri C, De Gaspari D, Pezzoli G, et al. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog. Parkinsonism & Related Disorders. 2013 Dec; 19(12): 1160- 3. http://dx.doi.org/10.1016/j.parkreldis.2013.08.008

Kalbe E, Calabrese P, Kohn N, Hilker R, Riedel O, Wittchen H-U, et al. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism & Related Disorders. 2008; 14(2): 93-101. http://dx.doi.org/10.1016/j.parkreldis.2007.06.008

Mattis S. Dementia Rating Scale: DRS: Professional Manual: PAR; 1988.

Karrasch M, Laatu S, Martikainen K, Marttila R. CERAD test performance and cognitive impairment in Parkinson's disease. Acta Neurologica Scandinavica. 2013 Dec; 128(6): 409-13. http://dx.doi.org/10.1111/ane.12138

Kulisevsky J, Fernandez de Bobadilla R, Pagonabarraga J, Martinez-Horta S, Campolongo A, Garcia-Sanchez C, et al. Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale. Parkinsonism & Related Disorders. 2013 Sep; 19(9): 812-7. http://dx.doi.org/10.1016/j.parkreldis.2013.05.007

Lieberman A, Dziatolowski M, Kupersmith M, Serby M, Goodgold A, Korein J, et al. Dementia in Parkinson disease. Annals of Neurology. 1979; 6(4): 355-9. http://dx.doi.org/10.1002/ana.410060409

Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology. 1991; 41(5): 634-43. http://dx.doi.org/10.1212/WNL.41.5.634

Marder K, Tang M-X, Cote L, Stern Y, Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Archives of Neurology. 1995; 52(7): 695-701. http://dx.doi.org/10.1001/archneur.1995.00540310069018

Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology. 2001 Mar 27; 56(6): 730-6. http://dx.doi.org/10.1212/WNL.56.6.730

Aarsland D, Kurz MW. The epidemiology of dementia associated with Parkinson disease. Journal of the Neurological Sciences. 2010 Feb 15; 289(1-2): 18-22. http://dx.doi.org/10.1016/j.jns.2009.08.034

Song I-U, Kim J-S, Jeong D-S, Song H-J, Lee K-S. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia. Parkinsonism & Related Disorders. 2008; 14(7): 558-62. http://dx.doi.org/10.1016/j.parkreldis.2008.01.007

Adler CH, Beach TG. Variability of diffuse plaques and amyloid angiopathy in Parkinson's disease with mild cognitive impairment. Acta Neuropathologica. 2010; 120(6).

Daniel S, Lees A. Parkinson's Disease Society Brain Bank, London: overview and research. Journal of Neural Transmission Supplementum. 1992; 39: 165-72.

Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Movement Disorders. 2007; 22(16): 2314- 24. http://dx.doi.org/10.1002/mds.21844

Schinka JA, Loewenstein DA, Raj A, Schoenberg MR, Banko JL, Potter H, et al. Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates. The American Journal of Geriatric Psychiatry. 2010; 18(8): 684-91. http://dx.doi.org/10.1097/JGP.0b013e3181e56d5a

Marras C, Armstrong MJ, Meaney CA, Fox S, Rothberg B, Reginold W, et al. Measuring mild cognitive impairment in patients with Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society. 2013 May; 28(5): 626-33.

Pedersen KF, Larsen JP, Tysnes OB, Alves G. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurology. 2013 May; 70(5): 580-6. http://dx.doi.org/10.1001/jamaneurol.2013.2110

Broeders M, de Bie RM, Velseboer DC, Speelman JD, Muslimovic D, Schmand B. Evolution of mild cognitive impairment in Parkinson disease. Neurology. 2013 Jul 23; 81(4): 346-52. http://dx.doi.org/10.1212/WNL.0b013e31829c5c86

Goldman JG, Holden S, Bernard B, Ouyang B, Goetz CG, Stebbins GT. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2013 Dec; 28(14): 1972-9.

Castro E. Profilo neuropsicologico dei soggetti con diagnosi di Parkinson's Disease-Mild Cognitive Impairment (PD-MCI). 2014.

Hassler R. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol. 1938; 48: 387-476.

Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Constantine GM, et al. Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. Journal of Neurology. 2006; 253(2): 242-7. http://dx.doi.org/10.1007/s00415-005-0971-0

Calabresi P, Picconi B, Parnetti L, Di Filippo M. A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine–acetylcholine synaptic balance. The Lancet Neurology. 2006; 5(11): 974-83. http://dx.doi.org/10.1016/S1474-4422(06)70600-7

Ferrer I. Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects. Progress in Neurobiology. 2009; 88(2): 89-103. http://dx.doi.org/10.1016/j.pneurobio.2009.02.004

Foltynie T, Cheeran B, Williams-Gray CH, Edwards MJ, Schneider SA, Weinberger D, et al. BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry. 2009; 80(2): 141-4. http://dx.doi.org/10.1136/jnnp.2008.154294

Alves G, Bronnick K, Aarsland D, Blennow K, Zetterberg H, Ballard C, et al. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. Journal of Neurology, Neurosurgery, and Psychiatry.

[Research Support, Non-U.S. Gov't]. 2010 Oct; 81(10): 1080-6.

Schulz-Schaeffer WJ. The synaptic pathology of ????-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathologica. 2010; 120(2): 131-43. http://dx.doi.org/10.1007/s00401-010-0711-0

Pagonabarraga J, Gomez-Anson B, Rotger R, Llebaria G, Garcia-Sanchez C, Pascual-Sedano B, et al. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease. Dementia and Geriatric Cognitive Disorders. 2012; 34(5-6): 312-8. http://dx.doi.org/10.1159/000345537

Beyer MK, Janvin CC, Larsen JP, Aarsland D. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. Journal of Neurology, Neurosurgery, and Psychiatry. 2007 Mar; 78(3): 254-9. http://dx.doi.org/10.1136/jnnp.2006.093849

Ekman U, Eriksson J, Forsgren L, Mo SJ, Riklund K, Nyberg L. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study. Lancet Neurology. 2012 Aug; 11(8): 679-87. http://dx.doi.org/10.1016/S1474-4422(12)70138-2

Noh SW, Han YH, Mun CW, Chung EJ, Kim EG, Ji KH, et al. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment. Journal of the Neurological Sciences. 2014; 347(1): 210-3. http://dx.doi.org/10.1016/j.jns.2014.09.049

Lee JE, Park HJ, Song SK, Sohn YH, Lee JD, Lee PH. Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease. Neurology. 2010 Nov 30; 75(22): 2009-16. http://dx.doi.org/10.1212/WNL.0b013e3181ff96bf

Ekman U, Eriksson J, Forsgren L, Domellöf ME, Elgh E, Lundquist A, et al. Longitudinal changes in task-evoked brain responses in Parkinson's disease patients with and without mild cognitive impairment. Frontiers in Neuroscience. 2014; 8.

Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Garcia-Diaz AI, et al. Cortical thinning associated with mild cognitive impairment in Parkinson's disease. Movement Disorders. 2014; 29(12): 1495-503. http://dx.doi.org/10.1002/mds.25982

Sinforiani E, Banchieri L, Zucchella C, Pacchetti C, Sandrini G. Cognitive rehabilitation in Parkinson's disease. Archives of Gerontology and Geriatrics. 2004; 38: 387-91. http://dx.doi.org/10.1016/j.archger.2004.04.049

Bäckman L, Nyberg L, Soveri A, Johansson J, Andersson M, Dahlin E, et al. Effects of working-memory training on striatal dopamine release. Science. 2011; 333(6043): 718. http://dx.doi.org/10.1126/science.1204978

París AP, Saleta HG, de la Cruz Crespo Maraver M, Silvestre E, Freixa MG, Torrellas CP, et al. Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease. Movement Disorders. 2011; 26(7): 1251-8. http://dx.doi.org/10.1002/mds.23688

Tanaka K, Quadros Jr ACd, Santos RF, Stella F, Gobbi LTB, Gobbi S. Benefits of physical exercise on executive functions in older people with Parkinson's disease. Brain Cogn. 2009; 69(2): 435-41. http://dx.doi.org/10.1016/j.bandc.2008.09.008

Nombela C, Bustillo PJ, Castell PF, Sanchez L, Medina V, Herrero MT. Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging. Frontiers in Neurology. 2011; 2.

Sportiello M, Cammisuli D, Tocchini S, Emanuela C, Matteo B, Michele G, editors. Mild cognitive impairment in Parkinson's disease: Preliminary findings. Movement Disorders; 2014: Wiley-Blackwell 111 River ST, Hoboken 07030-5774, NJ USA.

Ravina B, Marek K, Eberly S, Oakes D, Kurlan R, Ascherio A, et al. Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease. Movement Disorders. 2012; 27(11): 1392-7. http://dx.doi.org/10.1002/mds.25157

Reuter I, Mehnert S, Sammer G, Oechsner M, Engelhardt M. Efficacy of a multimodal cognitive rehabilitation including psychomotor and endurance training in Parkinson's disease. Journal of Aging Research. 2012; 2012.

Downloads

Published

2014-07-25

How to Cite

Castro, E., Sportiello, M. T., & Cammisuli, D. M. (2014). Neuropsychological Features of Mild Cognitive Impairment in Parkinson’s Disease: A Critical Review of the Literature. Journal of Aging and Gerontology, 2(2), 100–114. https://doi.org/10.12974/2309-6128.2014.02.02.5

Issue

Section

Articles